Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET097 in Obesity or Overweight (VESPER-3)
NCT06973720Phase 2Active, not recruiting
- Sponsor
- Pfizer
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PF-08653944 in obesity, sponsored by Pfizer. Started Apr 2025; status: active, not recruiting.
02
Drugs
PF-08653944
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06973720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06973720.